Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy. [electronic resource]
Producer: 20200206Description: 727-734 p. digitalISSN:- 1699-3993
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.